08048036315
Premium Exporter of Genuine MABTAS 100mg Injection from India to Singapore – Orchard | Phoenix Exim

1. General Information

Mabtas 100 mg Injection is a rituximab-based monoclonal antibody medicine belonging to the anti-CD20 class. Rituximab targets CD20-positive B lymphocytes and is used in selected cancers and autoimmune diseases.

  • Brand: Mabtas 100 mg Injection
  • Active ingredient: Rituximab 100 mg
  • Drug class: Anti-CD20 monoclonal antibody
  • Dosage form: Injection/solution for intravenous infusion
  • Manufacturer: Intas Pharmaceuticals Ltd.
  • Prescription: Required
  • Storage: Refrigerated, generally 2–8°C; do not freeze.

2. Product Information

Mabtas 100 mg Injection is supplied as a 10 mL presentation containing 100 mg of rituximab. It is administered by intravenous infusion by a qualified healthcare professional. The exact dose, dilution, infusion rate, and treatment schedule depend on the indication and the patient's medical condition.

Because rituximab is an immunomodulating medicine, appropriate medical assessment and monitoring are required before and during treatment.

3. Uses of Mabtas 100 mg Injection

Rituximab may be prescribed for:

  • Non-Hodgkin lymphoma (NHL)
  • Chronic lymphocytic leukemia (CLL)
  • Rheumatoid arthritis in appropriate patients, generally with methotrexate
  • Granulomatosis with polyangiitis (GPA)
  • Microscopic polyangiitis (MPA)
  • Pemphigus vulgaris in appropriate patients

The specific indication and treatment regimen should always be determined by the treating specialist.

4. Benefits of This Medicine

The potential therapeutic benefits of rituximab include:

  • Targets CD20-positive B cells involved in certain blood cancers.
  • Helps reduce abnormal B-cell activity in selected lymphomas and leukemias.
  • Can help control abnormal immune activity in certain autoimmune diseases.
  • Provides a targeted monoclonal-antibody treatment option for eligible patients.
  • May be used alone or alongside other medicines depending on the diagnosed condition and treatment protocol.

Important: Benefits vary according to the disease, treatment regimen, and individual patient response.

5. Side Effects of Mabtas 100 mg Injection

Possible adverse effects include:

  • Infusion-related reactions
  • Fever or chills
  • Headache
  • Nausea or vomiting
  • Rash or itching
  • Weakness or fatigue
  • Diarrhea
  • Changes in blood pressure
  • Increased susceptibility to infections
  • Reduced blood-cell counts

Serious reactions can occur, including severe infusion reactions, serious infections, hepatitis B reactivation, cardiac complications, and rare serious neurological complications. Immediate medical attention is required for severe or unusual symptoms.

6. Common Side Effects

Some commonly reported effects include:

  1. Headache
  2. Fever or chills
  3. Nausea
  4. Weakness or fatigue
  5. Rash
  6. Itching
  7. Diarrhea
  8. Blood-pressure changes
  9. Infusion-related reactions
  10. Increased risk of infections

The severity and frequency can differ depending on the indication and accompanying medicines.

7. How to Use Mabtas 100 mg Injection

Mabtas 100 mg Injection must not be self-administered.

It is given as an intravenous infusion by a trained healthcare professional, generally in a hospital or appropriate clinical setting. The doctor determines the dose and infusion schedule based on the condition being treated.

Before administration, healthcare professionals may assess the patient's medical history, infection status, blood counts, and other relevant clinical parameters.

8. How Mabtas 100 mg Injection Works

Mabtas contains rituximab, which specifically binds to the CD20 antigen on B lymphocytes. Once bound, rituximab helps eliminate these B cells through immune-mediated mechanisms, including antibody-dependent cellular cytotoxicity, complement-dependent cytotoxicity, and other cell-death mechanisms.

By reducing abnormal or overactive B cells, rituximab can help control certain B-cell cancers and selected autoimmune diseases.

9. Safety Advice

  • Use only under the supervision of a qualified healthcare professional.
  • Inform your doctor about active or recent infections before treatment.
  • Tell your doctor if you have previously had hepatitis B, heart problems, or other significant medical conditions.
  • Screening and monitoring for hepatitis B reactivation may be required.
  • Blood counts and other laboratory parameters may need regular monitoring.
  • Inform your doctor about all medicines, vaccines, and supplements you are taking.
  • Discuss pregnancy or plans to become pregnant with your doctor before treatment.
  • Breastfeeding considerations should be discussed with the treating physician.
  • Store the product under appropriate cold-chain conditions, generally 2–8°C, and do not freeze.
  • Seek urgent medical attention for breathing difficulty, severe rash/swelling, chest symptoms, severe infection symptoms, or other serious reactions.

10. FAQs

Q1. What is Mabtas 100 mg Injection?
Mabtas 100 mg Injection is a rituximab-containing monoclonal antibody medicine used for selected blood cancers and autoimmune conditions.

Q2. What is the active ingredient in Mabtas 100 mg?
The active ingredient is rituximab 100 mg.

Q3. What is Mabtas 100 mg used for?
It may be used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, GPA, MPA, and pemphigus vulgaris, depending on the approved indication and physician's assessment.

Q4. How is Mabtas 100 mg administered?
It is administered by intravenous infusion under professional medical supervision.

Q5. Can I inject Mabtas 100 mg myself?
No. It should be administered by a trained healthcare professional.

Q6. Does Mabtas require refrigeration?
Yes. The product is generally stored at 2–8°C and should not be frozen.

Q7. What are common side effects?
Headache, fever, chills, nausea, weakness, rash, itching, diarrhea, infections, and infusion-related reactions may occur.

Q8. Is Mabtas a prescription medicine?
Yes. Mabtas 100 mg is listed as a prescription medicine and should be used only under appropriate medical supervision.

Q9. Can Mabtas cause serious reactions?
Yes. Serious infusion reactions, severe infections, hepatitis B reactivation, and other serious complications are possible and require medical monitoring.

Q10. Can Mabtas 100 mg be substituted with another rituximab product?
A rituximab alternative may be available, but substitution should be made only by a qualified healthcare professional after confirming the active ingredient, strength, formulation, and treatment indication.

11. Substitutes for Mabtas 100 mg Injection

Examples of rituximab 100 mg alternatives listed by Indian medicine sources include:

  • Rituximab 100 mg Injection products from other manufacturers
  • Lupiximab 100 mg Injection
  • Unimab 100 mg Injection
  • X-Mab 100 mg Injection

These products should not be considered automatically interchangeable. The treating physician or pharmacist should verify the exact formulation, manufacturer, indication, and prescribed regimen before substitution.

12. SEO Keywords

Primary keywords:

  • Mabtas 100 mg Injection
  • Mabtas 100 mg Injection exporter
  • Mabtas 100 mg supplier
  • Mabtas 100 mg manufacturer
  • Mabtas 100 mg wholesaler
  • Mabtas 100 mg distributor
  • Rituximab 100 mg Injection
  • Rituximab 100 mg supplier
  • Rituximab Injection exporter from India
  • Mabtas 100 mg pharmaceutical exporter

Long-tail B2B keywords:

  • Mabtas 100 mg Injection exporter from India
  • Mabtas 100 mg Injection supplier from India
  • Mabtas 100 mg Injection wholesale supplier
  • Rituximab 100 mg Injection exporter from India
  • Rituximab 100 mg pharmaceutical supplier India
  • Mabtas 100 mg Injection international supplier
  • Mabtas 100 mg Injection bulk pharmaceutical supplier
  • Mabtas 100 mg Injection B2B supplier India
  • Mabtas 100 mg Injection supplier for USA
  • Mabtas 100 mg Injection supplier for UK
  • Mabtas 100 mg Injection supplier for Australia
  • Mabtas 100 mg Injection supplier for Singapore
  • Mabtas 100 mg Injection supplier for Canada
  • Mabtas 100 mg Injection supplier for South Korea
  • Mabtas 100 mg Injection supplier for UAE
  • Rituximab 100 mg Injection exporter to USA
  • Rituximab 100 mg Injection exporter to UK
  • Rituximab 100 mg Injection exporter to Australia
  • Rituximab 100 mg Injection exporter to Singapore
  • Rituximab 100 mg Injection exporter to Canada
  • Rituximab 100 mg Injection exporter to South Korea
  • Rituximab 100 mg Injection exporter to UAE
Aug 20th, 2026 3:30 PM

Keywords